Skip to content
DataLookout
Menu

NCT07594990

The MAI-FOIE Cohort

StatusRecruiting
PhaseNot specified
Primary completion (estimated)

At risk: Primary completion moved at least 10 years later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion pushed from May 30, 2028 to Jun 24, 2038 Show 6 more changesShow less
    • Recruitment opened
    • Eligibility criteria expanded, about 13 words
    • Study completion date: May 30, 2038 to Jun 24, 2038
    • Start date changed from estimate of Jun 1, 2026 to Jun 25, 2026
    • Site details revised at 13 of 13 sites
    • Collaborators: details revised at 1 of 10 entries
  2. Minor Trial sites expanded: 1 → 13 locationsv2
  3. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Identification of new immune, cellular and molecular markers in patients who respond and not respond to treatment
Timeframe: 2 years

Secondary (1)

Understanding the molecular mechanisms of treatment efficacy and failure

Arms and interventions

AIH patients

Patients of both sexes, over 10 years old, with an established diagnosis of AIH (Auto Immune Hepatitis) will be eligible for inclusion during a medical care visit.

Control patients

Patients of both sexes, over 18 years old, with an established diagnosis of Primary Biliary Cholangitis, Metabolic Steatohepatitis or Drug-Induced Hepatitis will be eligible for inclusion during a medical care visit

Sites

13 sites in 1 country